New biomarker may help diagnose ectopic pregnancies

Nov 04, 2010

Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). In the western world, deaths from ectopic pregnancy are not common but in the developing world one in ten women who are admitted with an ectopic pregnancy die.

An ectopic pregnancy is an abnormal pregnancy that occurs outside the uterine cavity. Most ectopic pregnancies take place in the Fallopian tube but implantation can also occur in the cervix, ovaries and abdomen. Ectopic pregnancy is associated with severe pelvic pain and the need for a blood transfusion. The condition is a leading cause of pregnancy-related first trimester deaths.

"Finding a simple and cost-effective test using biomarkers to diagnose ectopic pregnancies would have a significant impact on reducing emotional distress and unnecessary deaths," said Andrew Horne, PhD, of the University of Edinburgh in the United Kingdom and lead author of the study. "Our study shows that placental growth factor (PIGF), a key molecule in the formation of blood vessels, is a promising novel diagnostic biomarker for ectopic pregnancies."

In this study, researchers obtained trophoblast samples from 40 pregnant women aged 18-45 years undergoing surgical termination of pregnancy, evacuation of uterus for embryonic missed miscarriage or surgery for tubal ectopic pregnancy. Trophoblasts are specialized cells of the placenta that play an important role in embryo implantation. Serum PIGF levels were measured in all trophoblast samples and researchers found that PIGF was reduced in samples from tubal ectopic pregnancies when compare to intrauterine pregnancies.

"The inevitable multiple visits and tests that are currently necessary to diagnose ectopic pregnancies are a sizable expense for health services," said Horne. "Serum PIGF may be the answer to the urgent unmet need for a for tubal ectopic pregnancy that allows quicker diagnosis and facilitates earlier and less invasive treatment. Large-scale studies are now required to determine its clinical utility."

Explore further: Growing a blood vessel in a week

More information: The article, "Placental growth factor: a promising diagnostic biomarker for tubal ectopic pregnancy," will appear in the January 2011 issue of JCEM.

add to favorites email to friend print save as pdf

Related Stories

Risks in multiple pregnancies

Oct 08, 2010

The complication rate during pregnancy with twins is about 40%. Women with multiple pregnancies often develop pre-eclampsia, gestational diabetes, and hemorrhages during the term of their pregnancy. Joachim W Dudenhausen ...

Pregnancy outcome affected by immune system genes

Oct 25, 2010

A team of researchers, led by Ashley Moffett, at the University of Cambridge, United Kingdom, has shed new light on genetic factors that increase susceptibility to and provide protection from common disorders of pregnancy, ...

Pregnancy stress aids toddler development

May 18, 2006

Women who are stressed and anxious during pregnancy tend to have children who with more advanced mental and motor development by age 2, U.S. researchers say.

Recommended for you

Growing a blood vessel in a week

3 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

6 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0